Can Ophthalmic Drops Cause Central Nervous System Depression and Cardiogenic Shock in Infants?
- 1 November 2013
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Pediatric Emergency Care
- Vol. 29 (11), 1207-1209
- https://doi.org/10.1097/pec.0b013e3182aa1384
Abstract
Topical ocular medications have been widely prescribed and successfully used in children for the management of different ophthalmic disorders. We present 2 infants admitted to our pediatric intensive care unit who developed altered state of consciousness, hypotonia, hypothermia, bradycardia, and apnea after instillation of ophthalmic drops. The second infant also had hypotension and broncho-obstruction. Few days before admission, both infants were diagnosed with congenital glaucoma, and topical antiglaucoma treatment was initiated. Ophthalmic drops with brimonidine and brinzolamide were prescribed to both patients, whereas the second infant also received topical timolol. After elimination of other possible causes, the diagnosis of intoxication with topical antiglaucoma medications was established. After discontinuation of eye drops and vigorous symptomatic treatment, both infants recovered without sequels. Topically applied ophthalmic drops may cause life-threatening systemic adverse effects in infants, such as central nervous system depression and cardiogenic shock. Moreover, these 2 patients illustrate the importance of careful evaluation of all topical medications and their consideration as possible causes of the derangements in critically ill infants.Keywords
This publication has 26 references indexed in Scilit:
- The Safety and Efficacy of Glaucoma Medication in the Pediatric PopulationJournal of Pediatric Ophthalmology & Strabismus, 2009
- Brimonidine in the treatment of glaucoma and ocular hypertensionTherapeutics and Clinical Risk Management, 2006
- Systemic toxicity with topical ophthalmic medications in childrenPaediatric and Perinatal Drug Therapy, 2006
- Systemic Side Effects of Ophthalmic DropsClinical Pediatrics, 2004
- Safety and efficacy of brimonidine in children with glaucomaJournal of American Association for Pediatric Ophthalmology and Strabismus, 2001
- Apparent central nervous system depression in infants after the use of topical brimonidineAmerican Journal of Ophthalmology, 1999
- Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucomaEuropean Journal of Pediatrics, 1999
- Ocular Medications in ChildrenClinical Pediatrics, 1998
- Developing brain as a target of toxicity.Environmental Health Perspectives, 1995
- Pharmacokinetics of topically applied ophthalmic drugsSurvey of Ophthalmology, 1982